Genic

제닉 · 123330

Materials Chemicals · KOSDAQ

Small-cap

Market cap US$130.2M (₩179.7B)

Overview

Genic makes skin-care face masks, thin sheets or gel patches applied to the face to moisturise and treat skin, along with broader skin-care products such as creams and essences.

It supplies both under its own brands, including Celderma, and as a contract manufacturer (OEM/ODM) for global beauty companies. Listed on KOSDAQ, Korea's tech and small-cap board, the company earns the majority of its revenue from its hydrogel mask pack, a water-soluble gel format for which it holds manufacturing patents.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$56.7M

▲ +56.7% YoY

Operating profit · FY2025

US$10.9M

▲ +148.6% YoY

Net income · FY2025

US$13.7M

▲ +149.7% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$20.3M(₩28.1B)	US$36.2M(₩49.9B)	US$56.7M(₩78.2B)
Operating profit	−US$2.9M(−₩4B)	US$4.4M(₩6B)	US$10.9M(₩15B)
Net income	−US$3.2M(−₩4.4B)	US$5.5M(₩7.6B)	US$13.7M(₩18.9B)

Revenue

FY2023US$20.3M
FY2024US$36.2M
FY2025US$56.7M

Operating profit

FY2023−US$2.9M
FY2024US$4.4M
FY2025US$10.9M

Net income

FY2023−US$3.2M
FY2024US$5.5M
FY2025US$13.7M

Key ratios (FY2025)

ROE

46.0%

Debt/Eq

37.7%

Op. margin

19.1%

Net margin

24.1%

Rev. YoY

▲ +56.7%

Why it matters

Genic holds patents on its core water-soluble hydrogel mask-pack manufacturing technology, giving it a proprietary production process rather than relying on off-the-shelf methods.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?